(Circulation. 2000;101:1892.)
© 2000 American Heart Association, Inc.
Editorial |
From the Griffith Center, Division of Cardiology, Department of Medicine, Los Angeles County and University of Southern California Medical Center, Keck School of Medicine at USC, Los Angeles, Calif.
Key Words: Editorials stenosis valves systole
Severe calcific aortic
stenosis (AS) is an important clinical entity because (1) it is
the most common valve lesion being considered for valve replacement in
the United States,1 especially in older people. (2) More
people are living longer. In 1996, 36 million people in the United
States were
65 years old, and by 2020, this number is expected to
increase by 75%. (3) Aortic valve replacement (AVR) improves the
survival of symptomatic patients.1 2 The
relative survival of those
65 years old is better than those <65
years old.1 2 (4) The symptomatic state and
abnormal LV function improve or normalize in most
patients.1 2
Patients with a mean aortic valve gradient (AVG)
30 mm Hg
have been of concern. They may have severe AS even if left
ventricular (LV) ejection fraction (EF) is normal. The
clinical problem is magnified in those in whom LVEF is severely reduced
because of uncertainty about the cause of low LVEF and patient outcome
after AVR.
In this issue of Circulation, Connolly and
coworkers3 from the Mayo Clinic present important
data that clarify several issues but also raise other issues that need
to be addressed. Of 52 patients 71±11 years old (mean±SD) with aortic
valve area (AVA) of 0.7±0.2 cm2, mean AVG
<30 mm Hg, and LVEF <0.35, 86% were in NYHA functional classes
III and IV. The good news is that after AVR, (1) the 3-year
survival was 62%; (2) of the survivors, 47% were
asymptomatic and 30% were minimally
symptomatic (the improvement in
This article has been cited by other articles:
![]() |
D. Cramariuc, G. Cioffi, A. E. Rieck, R. B. Devereux, E. M. Staal, S. Ray, K. Wachtell, and E. Gerdts Low-Flow Aortic Stenosis in Asymptomatic Patients: Valvular-Arterial Impedance and Systolic Function From the SEAS Substudy J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 390 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
I G Burwash, M Lortie, P Pibarot, R A de Kemp, S Graf, G Mundigler, A Khorsand, C Blais, H Baumgartner, J G Dumesnil, et al. Myocardial blood flow in patients with low-flow, low-gradient aortic stenosis: differences between true and pseudo-severe aortic stenosis. Results from the multicentre TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study Heart, December 1, 2008; 94(12): 1627 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goland, A. Trento, K. Iida, L. S C Czer, M. De Robertis, T. Z Naqvi, K. Tolstrup, T. Akima, H. Luo, and R. J Siegel Assessment of aortic stenosis by three-dimensional echocardiography: an accurate and novel approach Heart, July 1, 2007; 93(7): 801 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bergler-Klein, G. Mundigler, P. Pibarot, I. G. Burwash, J. G. Dumesnil, C. Blais, C. Fuchs, D. Mohty, R. S. Beanlands, Z. Hachicha, et al. B-Type Natriuretic Peptide in Low-Flow, Low-Gradient Aortic Stenosis: Relationship to Hemodynamics and Clinical Outcome: Results From the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) Study Circulation, June 5, 2007; 115(22): 2848 - 2855. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Alkadhi, S. Wildermuth, A. Plass, D. Bettex, B. Baumert, S. Leschka, L. M. Desbiolles, B. Marincek, and T. Boehm Aortic Stenosis: Comparative Evaluation of 16-Detector Row CT and Echocardiography Radiology, July 1, 2006; 240(1): 47 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. L. Hu and J. F. Malouf 75-Year-Old Man With Progressive Shortness of Breath on Exertion Mayo Clin. Proc., December 1, 2005; 80(12): 1651 - 1654. [PDF] |
||||
![]() |
C Kupfahl, M Honold, G Meinhardt, H Vogelsberg, A Wagner, H Mahrholdt, and U Sechtem Evaluation of aortic stenosis by cardiovascular magnetic resonance imaging: comparison with established routine clinical techniques Heart, August 1, 2004; 90(8): 893 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A.M. Ahmed, A. N.J. Graham, D. Lovell, and H. O. O'Kane Management of mild to moderate aortic valve disease during coronary artery bypass grafting Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 535 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. John, T. Dill, R. R. Brandt, M. Rau, W. Ricken, G. Bachmann, and C. W. Hamm Magnetic resonance to assess the aortic valve area in aortic stenosis: How does it compare to current diagnostic standards? J. Am. Coll. Cardiol., August 6, 2003; 42(3): 519 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Malouf, M. Enriquez-Sarano, P. A. Pellikka, J. K. Oh, K. R. Bailey, K. Chandrasekaran, C. J. Mullany, and A. J. Tajik Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications J. Am. Coll. Cardiol., August 21, 2002; 40(4): 789 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Nishimura, J. A. Grantham, H. M. Connolly, H. V. Schaff, S. T. Higano, and D. R. Holmes Jr Low-Output, Low-Gradient Aortic Stenosis in Patients With Depressed Left Ventricular Systolic Function: The Clinical Utility of the Dobutamine Challenge in the Catheterization Laboratory Circulation, August 13, 2002; 106(7): 809 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Monin, M. Monchi, V. Gest, A.-M. Duval-Moulin, J.-L. Dubois-Rande, and P. Gueret Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: Risk stratification by low-dose dobutamine echocardiography J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2101 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schwammenthal, Z. Vered, Y. Moshkowitz, B. Rabinowitz, Z. Ziskind, A. K. Smolinski, and M. S. Feinberg Dobutamine Echocardiography in Patients With Aortic Stenosis and Left Ventricular Dysfunction : Predicting Outcome as a Function of Management Strategy Chest, June 1, 2001; 119(6): 1766 - 1777. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H Rahimtoola VALVE DISEASE: Should patients with asymptomatic mild or moderate aortic stenosis undergoing coronary artery bypass surgery also have valve replacement for their aortic stenosis? Heart, March 1, 2001; 85(3): 337 - 341. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |